The drug registration and approval process is a critical component of ensuring the safety, efficacy, and quality of pharmaceutical products before they reach the market. In Indonesia, the regulatory framework governing this process is overseen by the National Agency of Drug and Food Control (Badan Pengawas Obat dan Makanan, or BPOM). As the Indonesian pharmaceutical market continues to grow, understanding the complexities of the drug registration and approval process is essential for pharmaceutical companies, healthcare professionals, and policymakers. This article provides an in-depth look at the drug registration and approval process in Indonesia, highlighting the key steps, challenges, and opportunities …
